Avance Clinical Unveils Asia Growth Strategy at BIO Asia–Taiwan
TAIPEI, Taiwan | July 10, 2026 Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO), has announced its participation...
Breakthrough Therapy Designation
Advertisement
Leads Biolabs Secures Priority Review for Opamtistomig
NANJING, China | July 10, 2026 Nanjing Leads Biolabs Co., Ltd. has announced that the Center for Drug Evaluation...
InxMed Publishes Landmark Ifebemtinib NSCLC Trial Results
NANJING, China, July 9, 2026 InxMed Co., Ltd., a clinical-stage biotechnology company focused on overcoming cancer treatment resistance, has...
OKYO Pharma Receives FDA Support for Phase 3 Trial
LONDON and NEW YORK, July 8, 2026 OKYO Pharma announced positive feedback from its U.S. Food and Drug Administration...
Praxis and Remagine Collaborate on Ulixacaltamide
BOSTON, Mass. and AUSTIN, Texas, July 7, 2026 Praxis Precision Medicines and Remagine Labs have entered into a strategic...
Advertisements
Aligos Secures $25M Upfront in Greater China Deal
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Aligos Therapeutics has received a $25 million upfront payment from Xiamen Amoytop...
Qihan Biotech’s QT-019B Earns FDA RMAT and Breakthrough Therapy Designations
HANGZHOU, China, June 11, 2026 Qihan Biotech announced that its investigational universal dual-target CAR-T therapy QT-019B has received both...
Galmed and Tissue Dynamics Uncover Novel Pathway in Cardiac Fibrosis
REHOVOT and RAMAT-GAN, Israel, June 2, 2026 Galmed Pharmaceuticals and Tissue Dynamics have announced a significant preclinical breakthrough in...
Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Technology
SAN FRANCISCO, May 28, 2026 Alife Health has achieved a major milestone in reproductive medicine with the U.S. Food...
Ansun Biopharma Advances Phase 3 DAS181 Trial Following Positive DMC Review
SAN DIEGO, June 1, 2026 Ansun Biopharma has announced a significant clinical development milestone after an independent Data Monitoring...
Advertisement
